UA63015C2 - Composition for stimulating synthesis of melanic pigment, method for its production and method for treating vitiligo - Google Patents
Composition for stimulating synthesis of melanic pigment, method for its production and method for treating vitiligo Download PDFInfo
- Publication number
- UA63015C2 UA63015C2 UA2001010624A UA2001010624A UA63015C2 UA 63015 C2 UA63015 C2 UA 63015C2 UA 2001010624 A UA2001010624 A UA 2001010624A UA 2001010624 A UA2001010624 A UA 2001010624A UA 63015 C2 UA63015 C2 UA 63015C2
- Authority
- UA
- Ukraine
- Prior art keywords
- composition
- skin
- product
- treatment
- specified
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 238000000034 method Methods 0.000 title claims abstract description 14
- 206010047642 Vitiligo Diseases 0.000 title claims abstract description 12
- 230000004936 stimulating effect Effects 0.000 title claims description 4
- 239000000049 pigment Substances 0.000 title abstract description 7
- 230000015572 biosynthetic process Effects 0.000 title abstract description 4
- 238000003786 synthesis reaction Methods 0.000 title abstract description 4
- 238000004519 manufacturing process Methods 0.000 title description 3
- 238000011282 treatment Methods 0.000 claims abstract description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- 239000000047 product Substances 0.000 claims description 24
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 11
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 10
- 239000001110 calcium chloride Substances 0.000 claims description 10
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 10
- 201000010099 disease Diseases 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 8
- 239000005711 Benzoic acid Substances 0.000 claims description 6
- 235000010233 benzoic acid Nutrition 0.000 claims description 6
- 239000002244 precipitate Substances 0.000 claims description 6
- 210000002826 placenta Anatomy 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 230000008099 melanin synthesis Effects 0.000 claims description 4
- 239000012047 saturated solution Substances 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 102000004895 Lipoproteins Human genes 0.000 claims description 2
- 108090001030 Lipoproteins Proteins 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 230000003169 placental effect Effects 0.000 claims description 2
- 239000001488 sodium phosphate Substances 0.000 claims description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 1
- 210000002752 melanocyte Anatomy 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 12
- 210000003491 skin Anatomy 0.000 abstract description 12
- 239000003814 drug Substances 0.000 abstract description 7
- 230000035614 depigmentation Effects 0.000 abstract description 4
- 238000010517 secondary reaction Methods 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 3
- 230000002427 irreversible effect Effects 0.000 abstract description 2
- 230000037311 normal skin Effects 0.000 abstract description 2
- 230000000144 pharmacologic effect Effects 0.000 abstract description 2
- 230000003192 teratological effect Effects 0.000 abstract description 2
- 230000002110 toxicologic effect Effects 0.000 abstract description 2
- 231100000027 toxicology Toxicity 0.000 abstract description 2
- 238000003556 assay Methods 0.000 abstract 2
- 206010067482 No adverse event Diseases 0.000 abstract 1
- 230000000977 initiatory effect Effects 0.000 abstract 1
- 229930014626 natural product Natural products 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 239000006210 lotion Substances 0.000 description 20
- 208000012641 Pigmentation disease Diseases 0.000 description 11
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 230000019612 pigmentation Effects 0.000 description 7
- 210000005069 ears Anatomy 0.000 description 6
- 230000005855 radiation Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 229960004502 levodopa Drugs 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 101100123850 Caenorhabditis elegans her-1 gene Proteins 0.000 description 2
- 241000008374 Capirona Species 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 230000001744 histochemical effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- 206010024380 Leukoderma Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010040893 Skin necrosis Diseases 0.000 description 1
- 101100115801 Streptomyces mobaraensis daip gene Proteins 0.000 description 1
- 206010043268 Tension Diseases 0.000 description 1
- 239000012675 alcoholic extract Substances 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 231100000130 skin irritation / corrosion testing Toxicity 0.000 description 1
- 230000011273 social behavior Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/982—Reproductive organs; Embryos, Eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Developmental Biology & Embryology (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Pregnancy & Childbirth (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1998110A CU22695A1 (es) | 1998-07-28 | 1998-07-28 | Formulación para la estimulación de la síntesis del pigmento melánico |
| PCT/CU1999/000003 WO2000006180A1 (es) | 1998-07-28 | 1999-07-28 | Composicion para la estimulacion de la sintesis del pigmento melanico y procedimiento para su obtencion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA63015C2 true UA63015C2 (en) | 2004-01-15 |
Family
ID=5459380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2001010624A UA63015C2 (en) | 1998-07-28 | 1999-07-28 | Composition for stimulating synthesis of melanic pigment, method for its production and method for treating vitiligo |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6660305B1 (de) |
| EP (1) | EP1101494B1 (de) |
| JP (1) | JP2002521453A (de) |
| CN (1) | CN1187059C (de) |
| AR (1) | AR029307A1 (de) |
| AT (1) | ATE284699T1 (de) |
| BG (1) | BG105208A (de) |
| BR (1) | BR9913345A (de) |
| CA (1) | CA2336526A1 (de) |
| CU (1) | CU22695A1 (de) |
| DE (1) | DE69922662D1 (de) |
| HU (1) | HUP0103274A2 (de) |
| MX (1) | MXPA01001014A (de) |
| RU (1) | RU2225716C2 (de) |
| UA (1) | UA63015C2 (de) |
| WO (1) | WO2000006180A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1661565B1 (de) * | 2003-08-05 | 2007-10-24 | Centro de Histoterapia Placentaria | ZUSAMMENSETZUNG ENTHALTEND L-PROLINE ZUR BEHANDLUNG VON VITILIGO& x9;& x9; |
| RU2009117828A (ru) * | 2006-10-13 | 2010-11-20 | Релайанс Лайф Сайенсиз Пвт. Лтд. (In) | Культивированные меланоциты на биополимерах |
| EA013133B1 (ru) * | 2008-12-26 | 2010-02-26 | Некоммерческое Учреждение "Научно-Исследовательский Институт Цитохимии И Молекулярной Фармакологии" | Композиция аминокислот подъязычного применения для повышения репигментации кожного покрова при витилиго и способ ее применения |
| RU2405560C1 (ru) * | 2009-05-29 | 2010-12-10 | Общество С Ограниченной Ответственностью "Медицинский Исследовательский Центр "Иммункулус" | Средство для защиты клеток мозга |
| CN102266586B (zh) * | 2011-06-28 | 2013-12-04 | 江苏省人民医院 | 白癜风黑素细胞移植涂布载体系统的制备方法 |
| FR3051204B1 (fr) | 2016-05-10 | 2018-05-04 | Rkm | Engin roulant, notamment pour la depose au sol, sous forme d’un lit, de materiaux en vrac |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE454745B (sv) * | 1982-12-10 | 1988-05-30 | Cubana Importadora Y Exportado | Produkt for att stimulera syntesen av melanotiskt pigment i huden vid botande av vigiligo |
| US4507277A (en) * | 1983-04-08 | 1985-03-26 | Empresa Cubana Importadora Y Exportadora De Productos Medicos | Composition and method for stimulating the synthesis of the melanotic pigment of the skin |
| RU2040263C1 (ru) * | 1992-01-17 | 1995-07-25 | Научно-исследовательский институт текстильных материалов | Способ получения меланина |
| RU2083214C1 (ru) * | 1993-04-23 | 1997-07-10 | Голоунин Александр Васильевич | Способ получения меланина |
| BR9708390A (pt) * | 1996-03-28 | 2000-01-04 | Trustees O Boston University | Método para identificar uma substância que altera a pigmentação nos melanócitos epidérmicos de vertebrados, substância que inibe, intensifica ou modula a fosforização da tirosinase mediada pela proteìna c-beta quinase, uso de um agente que modula ou inibe a fosforização de um resìduo de serina ou de treonina mediada pela proteìna c-beta quinase, uso em peptìdeo que especificamente interfere na fosforização de resìduos de serina/treonina mediada pela proteìna c-beta quinase, uso de uma construção de dna ou de um peptìdeo para fabricar um medicamento para diminuir a pigmentação na pela, cabelo, lã ou pelo de vertebrados e uso de uma substância que modula a fosforização da tirosinase mediada pela proteìna c-beta quinase. |
| US5690966A (en) * | 1996-10-17 | 1997-11-25 | Council Of Scientific & Industrial Research | Process for the preparation of an extract from human placenta containing glycosphingolipids and endothelin-like constituent peptides useful for the treatment of vitiligo |
| US6451358B2 (en) * | 1999-12-29 | 2002-09-17 | Mileuna, Inc. | Composition and method for the treatment of vitiligo |
-
1998
- 1998-07-28 CU CU1998110A patent/CU22695A1/es unknown
-
1999
- 1999-07-27 AR ARP990103684A patent/AR029307A1/es unknown
- 1999-07-28 CA CA002336526A patent/CA2336526A1/en not_active Abandoned
- 1999-07-28 AT AT99934451T patent/ATE284699T1/de not_active IP Right Cessation
- 1999-07-28 JP JP2000562034A patent/JP2002521453A/ja active Pending
- 1999-07-28 EP EP99934451A patent/EP1101494B1/de not_active Expired - Lifetime
- 1999-07-28 WO PCT/CU1999/000003 patent/WO2000006180A1/es not_active Ceased
- 1999-07-28 DE DE69922662T patent/DE69922662D1/de not_active Expired - Lifetime
- 1999-07-28 HU HU0103274A patent/HUP0103274A2/hu unknown
- 1999-07-28 US US09/744,633 patent/US6660305B1/en not_active Expired - Lifetime
- 1999-07-28 UA UA2001010624A patent/UA63015C2/uk unknown
- 1999-07-28 BR BR9913345-8A patent/BR9913345A/pt not_active IP Right Cessation
- 1999-07-28 RU RU2001105539/15A patent/RU2225716C2/ru not_active IP Right Cessation
- 1999-07-28 CN CNB99810745XA patent/CN1187059C/zh not_active Expired - Fee Related
- 1999-07-28 MX MXPA01001014A patent/MXPA01001014A/es active IP Right Grant
-
2001
- 2001-01-31 BG BG105208A patent/BG105208A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CU22695A1 (es) | 2001-07-31 |
| DE69922662D1 (de) | 2005-01-20 |
| CA2336526A1 (en) | 2000-02-10 |
| HUP0103274A2 (hu) | 2002-01-28 |
| BR9913345A (pt) | 2001-10-16 |
| JP2002521453A (ja) | 2002-07-16 |
| HK1037520A1 (en) | 2002-02-15 |
| US6660305B1 (en) | 2003-12-09 |
| EP1101494A1 (de) | 2001-05-23 |
| CN1187059C (zh) | 2005-02-02 |
| MXPA01001014A (es) | 2002-06-04 |
| EP1101494B1 (de) | 2004-12-15 |
| AR029307A1 (es) | 2003-06-25 |
| WO2000006180A1 (es) | 2000-02-10 |
| BG105208A (en) | 2001-07-31 |
| ATE284699T1 (de) | 2005-01-15 |
| RU2225716C2 (ru) | 2004-03-20 |
| CN1316905A (zh) | 2001-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Olsen et al. | Topical minoxidil in male pattern baldness: effects of discontinuation of treatment | |
| KR100189144B1 (ko) | 신규 생리 활성 물질 | |
| CA3213489A1 (en) | Compositions comprising plant-derived exosome-like nanovesicles or exosomes and methods of use thereof | |
| RU2485133C2 (ru) | Белково-полипептидный комплекс, обладающий тканеспецифическим регенеративно-репаративным и омолаживающим действием на кожную ткань, способ его получения и фармацевтическая композиция на его основе | |
| US10940166B2 (en) | Bioassimilable protein-melanin complex, preparation and uses | |
| CZ293353B6 (cs) | Farmaceutický prostředek pro prevenci nebo léčení poruchy růstu vlasů | |
| RU2460736C1 (ru) | Белково-полипептидный комплекс (бпк), обладающий тканеспецифическим репаративным и омолаживающим действием на кожную ткань, способ получения белково-полипептидного комплекса, обладающего тканеспецифическим репаративным и омолаживающим действием на кожную ткань, и фармацевтическая композиция на основе бпк, обладающая антигипоксическим, иммуномодулирующим, тканеспецифическим репаративным действием на кожную ткань и слизистые оболочки, с омолаживающим эффектом | |
| RU2225716C2 (ru) | Композиция для стимуляции синтеза меланинового пигмента и способ ее получения | |
| US20100233305A1 (en) | Herbal extracts for treatment of chronic wounds | |
| CH404858A (de) | Verfahren zur Herstellung von wachstumfördernde Stoffe enthaltenden Präparaten | |
| RU2163129C1 (ru) | Способ получения из животного сырья комплекса биологически активных полипептидов, обладающих антиоксидантным и геропротекторным действием, фармакологическое средство и способ его применения | |
| CN118948707A (zh) | 夏枯草提取物和多肽螯合锌组合物及其在化妆品领域中的应用 | |
| Pathan et al. | Effect of some novel medicinal plants and polyherbal formulation on stress induced alopecia | |
| US4908206A (en) | Extracts of embryonic organs, process for their preparation and pharmaceutical preparation containing them | |
| CN107625956B (zh) | 一种木瓜蛋白酶组合物及其制备方法和应用 | |
| Shapiro et al. | Insulin iontophoresis in cystic fibrosis | |
| CN107823260A (zh) | 一种治疗黄褐斑的复方皮肤用乳膏剂、制备方法及应用 | |
| US4507277A (en) | Composition and method for stimulating the synthesis of the melanotic pigment of the skin | |
| KR20060121925A (ko) | 은행나무 플라바노이드에 의한 모발 성장 자극 | |
| Faddah et al. | Lactate dehydrogenase isoenzyme pattern in the liver tissue of chemically-injured rats treated by combinations of diphenyl dimethyl bicarboxylate. | |
| HK1037520B (en) | Composition for stimulating the synthesis of the melanic pigment and procedure to obtain it | |
| RU2341272C1 (ru) | Средство для неспецифической иммунотерапии | |
| CN109793763B (zh) | 一种用于减少皮下脂肪的茯苓提取物 | |
| GB2124900A (en) | Product for stimulating the synthesis of melanotic pigment in the skin | |
| CN120501680A (zh) | 骆驼刺提取物在皮肤外用制剂中的应用及其制备方法 |